CI Investments Inc
ANIK icon

CI Investments Inc’s Anika Therapeutics ANIK Stock Holding History

CI Investments Inc’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,884
Closed -$461K – 567
2019
Q4 		$461K Sell
8,884
-1,337
-13% -$77.7K ﹤0.01% 481
2019
Q3 		$561K Buy
+10,221
New +$525K ﹤0.01% 439

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CI Investments Inc's ANIK Position: Q1 2020 in Review

CI Investments Inc sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 8,884 shares — an estimated $461K sold.

CI Investments Inc first reported a position in ANIK in Q3 2019 and held it in 2 quarters. The position peaked at $561K in Q3 2019. 163 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • CI Investments Inc reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • CI Investments Inc sold 8,884 Anika Therapeutics shares in Q1 2020, an estimated $461K.
  • CI Investments Inc first reported a position in Anika Therapeutics in Q3 2019 and held it in 2 quarters.
  • CI Investments Inc's Anika Therapeutics position peaked at $561K in Q3 2019.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on CI Investments Inc's 13F filing for Q1 2020, filed 7 Aug 2020.